Chronic bilirubin encephalopathy: diagnosis and outcome
- PMID: 20116355
- DOI: 10.1016/j.siny.2009.12.004
Chronic bilirubin encephalopathy: diagnosis and outcome
Abstract
Chronic bilirubin encephalopathy (kernicterus) can be diagnosed using semi-objective criteria based on history, physical and neurological examination and laboratory findings including auditory brainstem responses and magnetic resonance imaging. Classical kernicterus is a well-described clinical tetrad of (i) abnormal motor control, movements and muscle tone, (ii) an auditory processing disturbance with or without hearing loss, (iii) oculomotor impairments, especially impairment of upward vertical gaze, and (iv) dysplasia of the enamel of deciduous teeth. Subtle kernicterus or bilirubin-induced neurologic dysfunction (BIND) refers to individuals with subtle neurodevelopmental disabilities without classical findings of kernicterus that, after careful evaluation and consideration, appear to be due to bilirubin neurotoxicity. Kernicterus can be further classified as auditory predominant or motor predominant and characterized based on the severity of clinical sequelae. Proposed research definitions for kernicterus diagnosis in infants from 3 to 18 months are reviewed, as are treatments of auditory and motor deficits and other complications of bilirubin encephalopathy.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND).J Perinatol. 2005 Jan;25(1):54-9. doi: 10.1038/sj.jp.7211157. J Perinatol. 2005. PMID: 15578034 Review.
-
Kernicterus in preterm infants.Pediatrics. 2009 Jun;123(6):e1052-8. doi: 10.1542/peds.2008-2791. Epub 2009 May 11. Pediatrics. 2009. PMID: 19433515
-
The Neurological Sequelae of Neonatal Hyperbilirubinemia: Definitions, Diagnosis and Treatment of the Kernicterus Spectrum Disorders (KSDs).Curr Pediatr Rev. 2017;13(3):199-209. doi: 10.2174/1573396313666170815100214. Curr Pediatr Rev. 2017. PMID: 28814249 Review.
-
Bilirubin and the auditory system.J Perinatol. 2001 Dec;21 Suppl 1:S52-5; discussion S59-62. doi: 10.1038/sj.jp.7210635. J Perinatol. 2001. PMID: 11803418
-
Prediction of 3- to 5-Month Outcomes from Signs of Acute Bilirubin Toxicity in Newborn Infants.J Pediatr. 2017 Apr;183:51-55.e1. doi: 10.1016/j.jpeds.2016.12.079. Epub 2017 Jan 25. J Pediatr. 2017. PMID: 28131490
Cited by
-
High unbound bilirubin for age: a neurotoxin with major effects on the developing brain.Pediatr Res. 2019 Jan;85(2):183-190. doi: 10.1038/s41390-018-0224-4. Epub 2018 Dec 5. Pediatr Res. 2019. PMID: 30518884 Review.
-
Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.CNS Neurosci Ther. 2015 Mar;21(3):262-70. doi: 10.1111/cns.12355. Epub 2014 Dec 12. CNS Neurosci Ther. 2015. PMID: 25495717 Free PMC article.
-
ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin.Neuromolecular Med. 2012 Dec;14(4):285-302. doi: 10.1007/s12017-012-8187-9. Epub 2012 Jun 17. Neuromolecular Med. 2012. PMID: 22707385
-
The differential value of radiomics based on traditional T1-weighted sequences in newborns with hyperbilirubinemia.BMC Med Imaging. 2023 Aug 24;23(1):112. doi: 10.1186/s12880-023-01075-6. BMC Med Imaging. 2023. PMID: 37620769 Free PMC article.
-
Umbilical cord blood acid-base analysis and the development of significant hyperbilirubinemia in near-term and term newborns: a cohort study.Ital J Pediatr. 2017 Aug 4;43(1):67. doi: 10.1186/s13052-017-0382-8. Ital J Pediatr. 2017. PMID: 28778173 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical